Usefulness of the Kyoto criteria as selection criteria for living donor liver transplantation for hepatocellular carcinoma
Toshimi Kaido, Yasutsugu Takada, Shinji Uemoto – 15 January 2010
Poor outcome after liver transplantation for transthyretin amyloid neuropathy in a family with an Ala36Pro transthyretin mutation: Case report
Kate R. Muller, Robert Padbury, Gary P. Jeffrey, Nicola K. Poplawski, Philip Thompson, Anne Tonkin, Hugh A. J. Harley – 15 January 2010 – Transthyretin amyloid polyneuropathy, caused by mutations in the transthyretin gene, is a progressive condition for which liver transplantation is an established treatment. Favorable outcomes have been described in patients with the most common transthyretin mutation, Val30Met, but outcomes have been variable in patients with other mutations.
Predictors of graft and patient survival in subjects undergoing transplantation for hepatitis C virus infection
Vinod K. Audimoolam, Mathew R. Foxton, Kosh Agarwal, John G. O'Grady, Michael A. Heneghan – 15 January 2010
Can children catch up in growth after living donor liver transplantation?
Walid Mohamed El Moghazy, Yasuhiro Ogura, Kouji Harada, Akio Koizumi, Shinji Uemoto – 15 January 2010 – Several studies have shown improved growth after liver transplantation, but long‐term follow‐up data have been lacking. This study was aimed at evaluating the ability of children to catch up in height after living donor liver transplantation (LDLT) and at clarifying factors affecting growth. Growth was assessed by serial height measurements performed during follow‐up.
Liver allocation for patients with hepatocellular carcinoma
James Neuberger – 15 January 2010
Primary liver transplantation for autoimmune hepatitis: A comparative analysis of the European Liver Transplant Registry
Christoph Schramm, Michael Bubenheim, René Adam, Vincent Karam, John Buckels, John G. O'Grady, Neville Jamieson, Stephen Pollard, Peter Neuhaus, Michael M. Manns, Robert Porte, Denis Castaing, Andreas Paul, Oscar Traynor, James Garden, Styrbjörn Friman, Bo‐Goran Ericzon, Lutz Fischer, Stefan Vitko, Marek Krawczyk, Herold J. Metselaar, Aksel Foss, Murat Kilic, Keith Rolles, Patrizia Burra, Xavier Rogiers, Ansgar W.
Perioperative coagulation profile in living liver donors as assessed by rotational thromboelastometry
Glauber Gouvêa, Rodrigo Diaz, Lúcio Auler, Renato Toledo, André Soluri, Alfredo G. Haack, Mariana M. de Oliveira, Bruno Vilanova, Virgínia R. Machado, José Manoel Martinho – 15 January 2010 – Transient postoperative coagulation abnormalities frequently occur in living liver donors, particularly after right liver resection. Usually, this coagulopathy is diagnosed by alterations in conventional coagulation tests (CCTs) such as the international normalized ratio (INR) of the prothrombin time.
Exchange living donor liver transplantation to overcome ABO incompatibility in adult patients
Shin Hwang, Sung‐Gyu Lee, Deok‐Bog Moon, Gi‐Won Song, Chul‐Soo Ahn, Ki‐Hun Kim, Tae‐Yong Ha, Dong‐Hwan Jung, Kwan‐Woo Kim, Nam‐Kyu Choi, Gil‐Chun Park, Young‐Dong Yu, Young‐Il Choi, Pyoung‐Jae Park, Hea‐Seon Ha – 15 January 2010 – ABO incompatibility is the most common cause of donor rejection during the initial screening of adult patients with end‐stage liver disease for living donor liver transplantation (LDLT). A paired donor exchange program was initiated to cope with this problem without ABO‐incompatible LDLT.
Pretransplant predictors of recovery of renal function after liver transplantation
Patrick G. Northup, Curtis K. Argo, Mihir R. Bakhru, Timothy M. Schmitt, Carl L. Berg, Mitchell H. Rosner – 15 January 2010 – The Model for End‐Stage Liver Disease system has given priority on the liver transplant waiting list to candidates with renal failure. This study determined the predictors of spontaneous recovery of renal function after transplantation in 1041 liver transplant recipients on renal replacement therapy (RRT) at the time of transplant (from February 2002 to January 2007).